CVS Health (CVS) to Release Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS) is scheduled to announce its earnings results before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of $1.69 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter in the prior year, the company posted $1.99 earnings per share. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. On average, analysts expect CVS Health to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

CVS Health Trading Down 1.6 %

NYSE:CVS opened at $68.50 on Wednesday. The company’s 50 day moving average price is $74.97 and its 200-day moving average price is $73.76. CVS Health has a 52 week low of $64.41 and a 52 week high of $83.25. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The stock has a market cap of $86.34 billion, a price-to-earnings ratio of 10.60, a PEG ratio of 0.92 and a beta of 0.52.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.88%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

Insiders Place Their Bets

In related news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on CVS shares. Wells Fargo & Company cut their price target on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a report on Monday, April 8th. Piper Sandler increased their price objective on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, March 15th. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Barclays started coverage on shares of CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective on the stock. Finally, SVB Leerink started coverage on shares of CVS Health in a research report on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.